Article
Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry.
Department of Psychiatry, University Hospital, Bern, Switzerland.
CNS spectrums (impact factor:
2.2).
08/2003;
8(7):515-21.
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Vagus nerve stimulation therapy system: in vitro evaluation of magnetic resonance imaging-related heating and function at 1.5 and 3 tesla.
[show abstract] [hide abstract]
ABSTRACT: Objectives. To evaluate magnetic resonance imaging-related (MRI-related) heating for the VNS Therapy System at 1.5 and 3 tesla (T) using various device configurations and MRI conditions and to assess device function before and after MRI. Methods. The VNS Therapy System (pulse generator, Model 102; leads Models 300 and 302; Cyberonics, Inc., Houston, Tex, USA) underwent assessment of MRI-related heating at 1.5 and 3 T using different positioning configurations, leads, transmit radiofrequency (RF) coils (body and head), RF power levels, and scans on different body regions. The function of the VNS Therapy System was evaluated before and after scanning. Results. At 1.5 T using a transmit RF body coil, excessive temperature changes were associated with scans of the C-spine/shoulder (+11.5°C, complete system; +29.5°C, lead without pulse generator). The lowest temperature change occurred for the scan of the L-spine. At 1.5 T using a transmit/receive RF head coil, temperature changes did not exceed +0.2°C under the conditions studied. At 3 T using a transmit RF body coil, the highest temperature change occurred with the scan of the C-spine/shoulder (+14.5°C) with the lead configured with no strain relief loops at the vagus nerve. MRI performed using various conditions at 1.5 and 3 T produced no significant alterations in the function of the VNS Therapy System. Conclusions. MRI-related heating was characterized for a variety of scenarios, identifying unsafe as well as safe conditions. Device function was unaffected by MRI procedures at 1.5 and 3 T. By following specific conditions, safety guidelines for the VNS Therapy System may be expanded beyond those currently indicated by the manufacturer.Neuromodulation 07/2006; 9(3):204-13. · 1.19 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
along-term treatment
clinical pilot studies
clinical significance
clinical usefulness
definite therapeutic effects
drug-resistant depression
drug-resistant depressive disorder
established treatment
interesting technique
large placebo-controlled trial
left vagus nerve
maintenance treatment
medically refractory partial onset seizures
multi-center pilot study
neuropsychiatric disorders
potential clinical usefulness
Recent data
research tool
severe side effect
Vagus nerve stimulation